NCT06194994

Brief Summary

The goal of this randomized controlled trial is to is to test emotion regulation as a moderator of two different treatments for children with Oppositional Defiant Disorder (ODD). The main question it aims to answer is whether treatment gains be increased when children with ODD receive a treatment congruent with their emotion regulation skill problems. Participants will be divided into two groups based on their response patterns; a high emotion dysregulation group and a low emotion dysregulation group. Within each group, children will then be randomly assigned to either a behavioral parent training intervention or a child directed treatment involving problem solving and emotion regulation skills.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
196

participants targeted

Target at P75+ for not_applicable

Timeline
44mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Jan 2024Dec 2029

First Submitted

Initial submission to the registry

June 22, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

January 4, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 8, 2024

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

January 8, 2024

Status Verified

January 1, 2024

Enrollment Period

3.9 years

First QC Date

June 22, 2023

Last Update Submit

January 5, 2024

Conditions

Keywords

Oppositional Defiant DisorderEmotion RegulationChild Psychopathology

Outcome Measures

Primary Outcomes (2)

  • Disruptive Behaviour Rating Scale

    Parent and teacher rated questionnaire to assess change in symptoms of ODD.

    Pre-treatment; Immediately post-treatment; 6-month follow-up; 18-month follow-up.

  • Schedule for Affective Disorders and Schizophrenia for School Aged Children (K-SADS-PL)

    Diagnostic Interview to assess whether a child changes in diagnostic status, whether child meets DSM-5 diagnostic criteria for mental disorders.

    Pre-treatment; 6-month follow-up; 18-month follow-up.

Secondary Outcomes (5)

  • Strength and difficulties questionnaire

    Pre-treatment; Immediately post-treatment; 6-month follow-up; 18-month follow-up.

  • Home Situations Questionnaire

    Pre-treatment; Immediately post-treatment; 6-month follow-up; 18-month follow-up.

  • Social Skills Rating System

    Pre-treatment; Immediately post-treatment; 6-month follow-up; 18-month follow-up.

  • Parent Stress Index

    Pre-treatment; Immediately post-treatment; 6-month follow-up; 18-month follow-up.

  • Pediatric Quality of Life Index

    Pre-treatment; Immediately post-treatment; 6-month follow-up; 18-month follow-up.

Study Arms (2)

Parent Training

EXPERIMENTAL

Behavioral parent training intervention. Individual sessions.

Behavioral: Parent Management Training

Child directed treatment

EXPERIMENTAL

Child directed cognitive behavioral therapy. Individual sessions.

Behavioral: Tuning Your Temper

Interventions

Behavioral parent training program aimed at increasing compliance and positive behaviours while decreasing disruptive behaviours

Parent Training

Cognitive behavioural treatment for children focusing on arousal reduction, problem solving and cognitive restructuring.

Child directed treatment

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosed with Oppositional Defiant Disorder
  • Icelandic speaking (child and parent/guardian)

You may not qualify if:

  • IQ below 70 (full scale score)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iceland

Reykjavik, 101, Iceland

RECRUITING

Related Publications (2)

  • Njardvik U, Smaradottir H, Ost LG. The Effects of Emotion Regulation Treatment on Disruptive Behavior Problems in Children: A Randomized Controlled Trial. Res Child Adolesc Psychopathol. 2022 Jul;50(7):895-905. doi: 10.1007/s10802-022-00903-7. Epub 2022 Feb 8.

    PMID: 35133557BACKGROUND
  • Barkley, R. A. (2013). Defiant children: A clinician's manual for assessment and parent training: Guilford press

    BACKGROUND

MeSH Terms

Conditions

Oppositional Defiant DisorderEmotional Regulation

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental DisordersSelf-ControlSocial BehaviorBehavior

Study Officials

  • Urdur Njardvik, PhD

    Department of Psychology, University of Iceland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Urdur Njardvik, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants, care providers and outcomes assessors will be blind to emotion regulation status.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomisation to two different treatments which will be compared.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 22, 2023

First Posted

January 8, 2024

Study Start

January 4, 2024

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2029

Last Updated

January 8, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

As the study includes repeated measures of a vulnerable population, parts of the data will be classified as sensitive personal data and thus restricted by the permit from the Bioethics Committee. We will consult with GAGNÍS (member of CESSDA ERIC) on how to make the data available according to the FAIR principles.

Locations